SCHEMBL17064774

SCHEMBL17064774

Nc1cc(C(CCC2CC2)c2ncc[nH]c2=O)ccc1F

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.33
PARP1 P09874 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17064825 0.83 KLKB1 (0.37) PARP1
SCHEMBL17064978 0.81 KLKB1 (0.39) PARP1
SCHEMBL17064373 0.81 AURKA (0.33)
SCHEMBL17064524 0.77 SLC6A2 (0.40) KCNH2
SCHEMBL17064816 0.74 HRH1 (0.40)
SCHEMBL17064553 0.72 TBXAS1 (0.36) KCNH2
SCHEMBL17064743 0.69 KLKB1 (0.33)
SCHEMBL25805122 0.69
SCHEMBL17064475 0.69 ADRB1 (0.35)
SCHEMBL17064372 0.66 KLKB1 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3113772-A1 HUMAN PLASMA KALLIKREIN INHIBITORS Biocryst Pharmaceuticals, Inc. (US) 2017-01-11 EP disclosed
WO-2015134998-A1 HUMAN PLASMA KALLIKREIN INHIBITORS BIOCRYST PHARMACEUTICALS, INC. (US) 2015-09-11 WO disclosed